These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28049654)

  • 41. Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
    Krishnan S; Horowitz S; Trievel RC
    Chembiochem; 2011 Jan; 12(2):254-63. PubMed ID: 21243713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Promising natural lysine specific demethylase 1 inhibitors for cancer treatment: advances and outlooks.
    Li ZR; Gu MZ; Xu X; Zhang JH; Zhang HL; Han C
    Chin J Nat Med; 2022 Apr; 20(4):241-257. PubMed ID: 35487595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deferiprone: Pan-selective Histone Lysine Demethylase Inhibition Activity and Structure Activity Relationship Study.
    Khodaverdian V; Tapadar S; MacDonald IA; Xu Y; Ho PY; Bridges A; Rajpurohit P; Sanghani BA; Fan Y; Thangaraju M; Hathaway NA; Oyelere AK
    Sci Rep; 2019 Mar; 9(1):4802. PubMed ID: 30886160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: a novel class of irreversible inhibitors of histone demethylase KDM1A.
    Vianello P; Botrugno OA; Cappa A; Ciossani G; Dessanti P; Mai A; Mattevi A; Meroni G; Minucci S; Thaler F; Tortorici M; Trifiró P; Valente S; Villa M; Varasi M; Mercurio C
    Eur J Med Chem; 2014 Oct; 86():352-63. PubMed ID: 25173853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro histone demethylase assays.
    Kokura K; Sun L; Fang J
    Methods Mol Biol; 2015; 1288():109-22. PubMed ID: 25827878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oncoepigenomics: making histone lysine methylation count.
    Decarlo D; Hadden MK
    Eur J Med Chem; 2012 Oct; 56():179-94. PubMed ID: 22975593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
    Liu K; Liu Y; Lau JL; Min J
    Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorinated tranylcypromine analogues as inhibitors of lysine-specific demethylase 1 (LSD1, KDM1A).
    Borrello MT; Schinor B; Bartels K; Benelkebir H; Pereira S; Al-Jamal WT; Douglas L; Duriez PJ; Packham G; Haufe G; Ganesan A
    Bioorg Med Chem Lett; 2017 May; 27(10):2099-2101. PubMed ID: 28390942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone lysine demethylases in Drosophila melanogaster.
    Holowatyj A; Yang ZQ; Pile LA
    Fly (Austin); 2015; 9(1):36-44. PubMed ID: 26207949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lysine-specific demethylase 1 as a potential therapeutic target.
    Stavropoulos P; Hoelz A
    Expert Opin Ther Targets; 2007 Jun; 11(6):809-20. PubMed ID: 17504018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CD86 expression as a surrogate cellular biomarker for pharmacological inhibition of the histone demethylase lysine-specific demethylase 1.
    Lynch JT; Cockerill MJ; Hitchin JR; Wiseman DH; Somervaille TC
    Anal Biochem; 2013 Nov; 442(1):104-6. PubMed ID: 23911524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Emerging of lysine demethylases (KDMs): From pathophysiological insights to novel therapeutic opportunities.
    Arifuzzaman S; Khatun MR; Khatun R
    Biomed Pharmacother; 2020 Sep; 129():110392. PubMed ID: 32574968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. KIAA1718 is a histone demethylase that erases repressive histone methyl marks.
    Yokoyama A; Okuno Y; Chikanishi T; Hashiba W; Sekine H; Fujiki R; Kato S
    Genes Cells; 2010 Aug; 15(8):867-73. PubMed ID: 20629981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases.
    Yu V; Fisch T; Long AM; Tang J; Lee JH; Hierl M; Chen H; Yakowec P; Schwandner R; Emkey R
    J Biomol Screen; 2012 Jan; 17(1):27-38. PubMed ID: 21859682
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone demethylase lysine demethylase 5B in development and cancer.
    Han M; Xu W; Cheng P; Jin H; Wang X
    Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chemoprobe-based assays of histone lysine demethylase 1A target occupation enable
    Mascaró C; Ortega A; Carceller E; Ruiz Rodriguez R; Ciceri F; Lunardi S; Yu L; Hilbert M; Maes T
    J Biol Chem; 2019 May; 294(20):8311-8322. PubMed ID: 30804215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
    Eglen RM; Reisine T
    J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. KDM4 Demethylases: Structure, Function, and Inhibitors.
    Jiang Y; Liu L; Yang ZQ
    Adv Exp Med Biol; 2023; 1433():87-111. PubMed ID: 37751137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.
    Wang Z; Patel DJ
    Q Rev Biophys; 2013 Nov; 46(4):349-73. PubMed ID: 23991894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.